Synthesis, Characterization, Docking, and Biological Activity of Cobalt(II), Nickel(II), and Copper(II) Complexes with New Bidentate Derivative of Isoniazid

Aya Waleed Al-Samarai; Mahmoud Najim Aljibouri; Salam Abbas Hassan Al-Ameri

doi:10.22146/ijc.106797

Synthesis, Characterization, Docking, and Biological Activity of Cobalt(II), Nickel(II), and Copper(II) Complexes with New Bidentate Derivative of Isoniazid

https://doi.org/10.22146/ijc.106797

Aya Waleed Al-Samarai⁽¹⁾, Mahmoud Najim Aljibouri^(2*), Salam Abbas Hassan Al-Ameri⁽³⁾

(1) Alkarkh Third Education Directorate, Ministry of Education, Al-Kadhimiya, Baghdad 10006, Iraq
(2) Department of Chemistry, College of Science, Mustansiriyah University, Baghdad 10001, Iraq
(3) Department of Chemistry, College of Science, Mustansiriyah University, Baghdad 10001, Iraq
(*) Corresponding Author

Abstract

Coordination compounds were prepared from transition metals (cobalt(II), nickel(II), and copper(II)) and two new bidentate Schiff base-based isoniazid ligands, HL¹ and HL², via condensation reaction of isoniazid with glyoxylic acid and 5-bromo-thiophene-2-carboxaldehyde. The synthesized isoniazid Schiff bases and their metal complexes were characterized based on elemental analyses (C, H, N, and S), metal content using FAAS, FTIR, UV-vis, NMR spectra, molar conductivity, and magnetic susceptibility measurements. The analytical and spectroscopic results confirmed that all metal complexes were octahedral except nickel(II) and copper(II) complexes formed with HL² ligand were tetrahedral and pseudo-tetrahedral geometry, respectively. From the molecular docking result, HL¹ demonstrates a stable association by forming six hydrogen bonds, mostly with Arg20, and displaying a binding energy of 46.86 kcal/mol. HL² had a greater binding energy of 53.21 kcal/mol, generating two hydrogen bonds with Phe113. These results show that both compounds act as biologically active agents, reinforcing the importance of molecular types of interaction in predicting biological activity. According to the biological activity results, free ligands exhibited little to no effect, while most metal complexes, especially those of cobalt, demonstrated strong antibacterial and antifungal activity. In contrast, nickel and copper complexes exhibited moderate activity.

Keywords

isoniazid complexes; molecular docking; biological activity

Full Text:

Full Text PDF Full Text PDF-Suppl. Data

References

[1] Kaur, M., Vriender, V., Kumar, A., and Kumar Dubey, S., 2025, An isonazid-based reversible Schiff base chemosensor for multi-analyte (Cu²⁺, Ni²⁺, Hg²⁺ detection), Polyhedron, 265, 117282.

[2] Sami, S., and Shaalan, N., 2024, Synthesis, structure, and biological activity studies of new metal ion complexes based on 3-[(3-hydroxynaphthalene-2-yl-ethylidene)-hydrazono]-1,3-dihydro-indol-2-one, Indones. J. Chem., 24 (2), 370–378.

[3] Yasir, A.F., and Jamel, H.O., 2023, Synthesis of a new DPTYEAP ligand and its complexes with their assessments on physical properties, antioxidant, and biological potential to treat breast cancer, Indones. J. Chem., 23 (3), 796–808.

[4] Reddy, K.K., Rao, S., and Rao, B.S., 2015, Synthesis and characterization and biological activities of hydrazones, Int. J. Innovative Res. Sci., Eng. Technol., 4 (1), 18944–18952.

[5] Noor, S.S., and Kareem, I.K., 2024, Exploring the anticancer activity of gold complex with newly ligand (DDIBM): Synthesis, spectral identification and magnetic susceptibility of its metallic complexes, Indones. J. Chem., 24 (3), 822–834.

[6] Yarullin, D.N., Slavova, S.O., Abramova, E.O., Zavalishin, M.N., Tolstoy, P.M., Gamov, G.A., and Grachova, E.V., 2025, Conformer-specific differences in solid-phase emission of pyridoxal 5′-phosphate hydrazones containing heteroaromatic cycles, Opt. Mater., 159, 116593.

[7] Kargar, H., Fallah-Mehrjardi, M., Ashfaq, M., Munawar, K.S., and Tahir, M.N., 2023, Cis-dioxomolybdenum(VI) complex bearing tridentate ONO isonicotinoyl hydrazone Schiff base: Synthesis, characterization, crystal structure, and catalytic activity investigation for the oxidation of sulfides, J. Mol. Struct., 1294 (Pt. 2), 136458.

[8] Abou-Melha, K.S., 2008, Transition metal complexes of isonicotinic acid (2-hydroxybenzylidene)hydrazide, Spectrochim. Acta, Part A, 70 (1), 162–170.

[9] Sogukomerogullari, H.G., Başaran, E., Çakmak, R., Muhammed, M.T., and Akkoc, S., 2025, Novel transition metal(II) complexes of hydrazones as potential antitumor agents: Synthesis, characterization, DFT computations, cytotoxic activities, molecular docking and simulation studies, Inorg. Chim. Acta, 581, 122634.

[10] Abbas, H.H., Al-Luaibi, M.Y., and Al-Assadi, M.J., 2023, New heterocyclic organo-chalcogenide compounds: Synthesis, physicochemical characterization, and evaluation of anti-cancer activity against breast cancer cells, Indones. J. Chem., 23 (2), 309–320.

[11] Khodair, A.I., Imam, D.R., Kheder, N.A., Fahim, A.M., and El-Barbary, A.A., 2025, Synthesis, DFT investigation, molecular docking analysis, ADMET studies, and biological evaluation of a novel series of imidazolidinone derivatives as potential antimicrobial agents, J. Mol. Struct., 1322 (Pt. 4), 140586.

[12] Wazalwar, S.S., Banpurkar, A.R., and Perdih, F., 2022, Single crystal structure of 3-(2-(3-acetylphenyl)hydrazono)pentane-2,4-dione and molecular docking study with CYP450 members for anticancer molecular screening, J. Indian Chem. Soc., 99 (6), 100482.

[13] Kargar, H., Fallah-Mehrjardi, M., and Munawar, K.S., 2024, Metal complexes incorporating tridentate ONO pyridyl hydrazone Schiff base ligands: Crystal structure, characterization and applications, Coord. Chem. Rev., 501, 215587.

[14] Islam, M.A., Tasnim, F., Hossain, M., Hossen, M.F., Zahan, M.K.E., and Asraf, M.A., 2025, Experimental and computational insights into antibacterial and antioxidant properties of metal complexes with isoniazid-based Schiff base ligands, J. Mol. Struct., 1324, 140916.

[15] Pahonțu, E., Ilieș, D.C., Shova, S., Oprean, C., Păunescu, V., Olaru, O.T., Rădulescu, F.S., Gulea, A., Roșu, T., and Drăgănescu, D., 2017, Synthesis, characterization, antimicrobial and antiproliferative activity evaluation of Cu(II), Co(II), Zn(II), Ni(II) and Pt(II) complexes with isoniazid-derived compound, Molecules, 22 (4), 650.

[16] El-Etrawy, A.A.S., and Sherbiny, F.F., 2021, Design, synthesis, biological evaluation and molecular modeling investigation of new N'-(2-thiouracil-5-oyl) hydrazone derivatives as potential anti-breast cancer and anti-bacterial agents, J. Mol. Struct., 1232, 129993.

[17] Kalay, E., Korkmaz, I.N., Kacı, F.N., Aslan, O.N., Güller, P., Tokalı, F.S., and Kalın, R., 2025, Design, synthesis, and biological studies of isoniazid-based hydrazone derivatives: Antibacterial, anticancer, and enzyme inhibitory properties, Arch. Biochem. Biophys., 770, 110450.

[18] Çakmak, R., Başaran, E., Kaya, S., and Erkan, S., 2022, Synthesis, spectral characterization, chemical reactivity and anticancer behaviors of some novel hydrazone derivatives: Experimental and theoretical insights, J. Mol. Struct., 1253, 132224.

[19] Ridhay, A.N., Noor, A., Soekamto, N.H., Harlim, T., and van Altena, I., 2012, A stigmasterol glycoside from the root wood of Melochia umbellata (Houtt) Stapf var. degrabrata K., Indones. J. Chem., 12 (1), 100–103.

[20] Devraye, S., Jadhav, S., and Zangade, S., 2025, Preparation, structure elucidation, free radical scavenging, in-vitro antimicrobial and cytotoxic proficiency of isoniazid incorporated tridentate Co(II), Ni(II), Cu(II) and Zn(II) Schiff base-metal complexes, Results Chem., 16, 102407.

[21] Ferraresi-Curotto, V., Echeverría, G.A., Piro, O.E., Pis-Diez, R., and González-Baró, A.C., 2017, Synthesis and characterization of a series of isoniazid hydrazones. Spectroscopic and theoretical study, J. Mol. Struct., 1133, 436–447.

DOI: https://doi.org/10.22146/ijc.106797